Richard Becker, MD
Staff Affiliate - OtherCards
About
Research
Publications
2024
Bridging the gap: strategies for recognizing and managing post-COVID conditions
Khan M, Becker R. Bridging the gap: strategies for recognizing and managing post-COVID conditions. Frontiers In Medicine 2024, 11: 1395420. PMID: 39635598, PMCID: PMC11615723, DOI: 10.3389/fmed.2024.1395420.Peer-Reviewed Original ResearchQuality of lifePost-COVID conditionsTargeted interventionsPrevalence of chronic conditionsStandardized screening toolPatient-centered approachPrevalence of post-COVID conditionImprove quality of lifeHigh-risk individualsPsychosocial healthHealthcare providersChronic conditionsCardiovascular healthEarly diagnosisImprove qualityScreening toolPeripheral vascular diseaseCommunity leadersComorbid conditionsDevelopment of screening strategiesPersistent symptomsCost-effective screening approachHealthAffected individualsInterventionPATCH (Preferred Attachment Strategy for Optimal Electrocardiograms)-1 Study
Becker R, Harnett B, Wayne D, Mardis R, Meganathan K, Steen D. PATCH (Preferred Attachment Strategy for Optimal Electrocardiograms)-1 Study. Clinical Research In Cardiology 2024, 114: 497-506. PMID: 39527276, DOI: 10.1007/s00392-024-02572-6.Peer-Reviewed Original ResearchStable cardiovascular diseaseAmbulatory clinic visitsAmbulatory clinic settingCardiovascular diseaseS-ECGClinical research coordinatorsClinical indicationsClinic visitsResearch coordinatorsValvular heart diseaseCoronary artery diseaseMedical practiceParticipantsEssential hypertensionClinical settingLead placementAtrial fibrillationHeart diseaseHeart failureTreatment decisionsArtery diseaseST-TElectrocardiographyBaselineHeart rhythmSystolic Blood Pressure, Cardiovascular Health, and Neurocognition in Adolescents
Hooper S, Lande M, Flynn J, Hanevold C, Meyers K, Samuels J, Becker R, Daniels S, Falkner B, Ferguson M, Ingelfinger J, Martin L, Mitsnefes M, Khoury P, Seo J, Urbina E. Systolic Blood Pressure, Cardiovascular Health, and Neurocognition in Adolescents. Hypertension 2024, 81: 2444-2453. PMID: 39291378, PMCID: PMC11578784, DOI: 10.1161/hypertensionaha.124.22834.Peer-Reviewed Original ResearchParent ratings of executive functioningRatings of executive functionSystolic blood pressureLow nonverbal IQCardiovascular risk factorsNonverbal IQVerbal attentionCardiovascular healthExecutive functionParent ratingsRisk factorsAssociated with parent ratingsAmbulatory systolic blood pressureHealth risk indicatorsNeurocognitive outcomesCross-sectional studyAcademic medical centerAssociated with neurocognitionHigh school degreeElevated systolic blood pressureAssociated with neurocognitive outcomesBlood pressureBlood pressure measurementsClinical carePrimary exposureThe COVID-19 thrombus: distinguishing pathological, mechanistic, and phenotypic features and management
Becker R, Tantry U, Khan M, Gurbel P. The COVID-19 thrombus: distinguishing pathological, mechanistic, and phenotypic features and management. Journal Of Thrombosis And Thrombolysis 2024, 58: 15-49. PMID: 39179952, PMCID: PMC11762605, DOI: 10.1007/s11239-024-03028-4.Peer-Reviewed Original ResearchNeutrophil extracellular trapsMild to moderate illnessHost immunoinflammatory responseOptimal patient managementSARS-CoV-2SARS-CoV-2 infectionEndothelial cell inflammationVascular endothelial cellsSurveillance modalitiesClinical featuresOrgan injuryImmunoinflammatory responseMicrovascular thrombosisInflammatory signatureAtherothrombotic phenotypeCirculating monocytesChronic phasePatient managementVascular eventsAcute phaseExtracellular trapsCritical illnessThrombosisEndothelial cellsMedical literatureThe journal of thrombosis and thrombolysis: commemorating the written word in science and medicine: three decades and counting
Becker R. The journal of thrombosis and thrombolysis: commemorating the written word in science and medicine: three decades and counting. Journal Of Thrombosis And Thrombolysis 2024, 57: 1103-1108. PMID: 38980568, DOI: 10.1007/s11239-024-03012-y.Peer-Reviewed Original ResearchMilvexian: evaluating the factor XIa inhibitor for the treatment of acute coronary syndrome
Tantry U, Raghavakurup L, Becker R, Singh S, Bliden K, Gurbel P. Milvexian: evaluating the factor XIa inhibitor for the treatment of acute coronary syndrome. Expert Opinion On Pharmacotherapy 2024, 25: 1271-1280. PMID: 39072402, DOI: 10.1080/14656566.2024.2385062.Peer-Reviewed Original ResearchConceptsAcute coronary syndromeCoronary syndromeElevated risk of bleedingPathological thrombosisTreatment of acute coronary syndromesClinical thrombotic eventsPhysiological hemostasisRisk of bleedingPrevention of thrombosisFXIa inhibitorsBleeding riskReceptor blockersThrombotic eventsAntiplatelet therapyPlatelet antagonistsAntithrombotic efficacyFXIa inhibitionThrombosisExperimental thrombosisPatientsElevated riskLiterature searchAnticoagulationLarge-scale studiesFXIaAssessment of Days Alive Out of Hospital as a Possible End Point in Trials of Stroke Prevention for Atrial Fibrillation: A ROCKET AF Analysis
Harrington J, Hellkamp A, Mahaffey K, Breithardt G, Halperin J, Hankey G, Becker R, Nessel C, Berkowitz S, Fox K, Singer D, Goodman S, Patel M, Piccini J. Assessment of Days Alive Out of Hospital as a Possible End Point in Trials of Stroke Prevention for Atrial Fibrillation: A ROCKET AF Analysis. Journal Of The American Heart Association 2024, 13: e028951. PMID: 38780169, PMCID: PMC11255646, DOI: 10.1161/jaha.122.028951.Peer-Reviewed Original ResearchAtrial fibrillationROCKET AFClinical trialsEnd pointsLow overall event ratesInternational double-blindClinical trials of interventionsRandomized clinical trialsAssessment of dayOverall event rateDouble-blindAnticoagulation trialsTreatment armsIncreased riskWarfarinTrials of interventionsClinical utilityTreatment groupsEvent ratesPatientsDAOHPoisson regressionComorbiditiesFibrillationTrialsThe foundation for investigating factor XI as a target for inhibition in human cardiovascular disease
Ali A, Becker R. The foundation for investigating factor XI as a target for inhibition in human cardiovascular disease. Journal Of Thrombosis And Thrombolysis 2024, 57: 1283-1296. PMID: 38662114, PMCID: PMC11645312, DOI: 10.1007/s11239-024-02985-0.Peer-Reviewed Original ResearchConceptsCardiovascular diseaseCoronary syndromeChronic coronary syndromeFactor XIManagement of patientsSusceptible to pharmacological inhibitionAcute coronary syndromeHuman cardiovascular diseaseAnticoagulant therapyImmune dysregulationSystemic inflammationAtrial fibrillationClinical trialsPharmacological inhibitionTargeted drugsThrombosisIschemic strokeReparative capabilitiesPhenotypic expressionEnvironmental triggersOxidative stressDay-to-day patient careMolecular eventsSyndromeDiseaseFactor XI: structure, function and therapeutic inhibition
Ali A, Becker R. Factor XI: structure, function and therapeutic inhibition. Journal Of Thrombosis And Thrombolysis 2024, 57: 1315-1328. PMID: 38622277, PMCID: PMC11645426, DOI: 10.1007/s11239-024-02972-5.Peer-Reviewed Original ResearchFactor XI inhibitorsVitamin K antagonistsEnd-stage renal diseaseFactor XITraditional anticoagulantsSafety profileInherent risk of bleedingPhase 3 clinical trialsPhase 2 studyMultiple coagulation factorsRisk of bleedingFactor XI deficiencyIntrinsic pathway of coagulationPathway of coagulationFXI inhibitorsK antagonistsOral anticoagulantsAnticoagulant therapyTherapeutic anticoagulationVenous thromboembolismPreclinical studiesAtrial fibrillationClinical endpointsRenal diseaseClinical trialsTemporal biomarker concentration patterns during the early course of acute coronary syndrome
Eggers K, Batra G, Lindahl B, Lakic T, Lindbäck J, Budaj A, Cornel J, Giannitsis E, Katus H, Storey R, Becker R, Siegbahn A, Wallentin L. Temporal biomarker concentration patterns during the early course of acute coronary syndrome. Clinical Chemistry And Laboratory Medicine 2024, 62: 1167-1176. PMID: 38341860, DOI: 10.1515/cclm-2023-1253.Peer-Reviewed Original ResearchAcute coronary syndromeST-elevation myocardial infarctionSymptom onsetNSTE-ACSHs-cTnTGDF-15Concentrations of high-sensitivity cardiac troponin TNon-ST-elevation acute coronary syndromeHigh-sensitivity cardiac troponin TPro-B-type natriuretic peptideBiomarker patternsAcute coronary syndrome patientsGrowth differentiation factor 15Cardiac troponin TC-reactive proteinPathophysiological processesBiomarker concentrationsClinically useful informationPlatelet inhibitionNatriuretic peptideHs-cTnICoronary syndromeTroponin TEarly courseAssociated with time
Clinical Care
Overview
Clinical Specialties
Radiology & Biomedical Imaging
Board Certifications
Diagnostic Radiology
- Certification Organization
- AB of Radiology
- Original Certification Date
- 1984
Get In Touch
Contacts
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.